In contrast to its immunogenic counterpart MOC1, the poorly immunogenic carcinoma cell line MOC2 showed little expression of RIPK3 and consequently no susceptibility to TSZ-induced necroptotic cell death in vitro (online supplemental figure S6A-B). This evidence concerns the gene RIPK3 and carcinoma.